The disease exacerbations analyzed included relapses (n=40), defined as an increase in BVAS/WG following a achievement of remission, and flares (n=4), defined as an increase in BVAS/WG before achieving remission
The disease exacerbations analyzed included relapses (n=40), defined as an increase in BVAS/WG following a achievement of remission, and flares (n=4), defined as an increase in BVAS/WG before achieving remission. more glucocorticoids than those who managed remission (6.7 grams versus 3.8 grams [p 0.01]). Bottom line Treatment of non-severe relapses in AAV with a rise…